SLLN-15
SLLN-15 is an oral active, selective and potent enhancer of autophagy that activates cytostatic macroautophagy/autophagy in triple-negative breast cancer (TNBC) [1].
Product Specifications
CAS Number
[2403650-93-9]
UNSPSC
12352005
Target
Autophagy
Type
Reference compound
Related Pathways
Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SLLN-15.html
Solubility
10 mM in DMSO
Smiles
C12=NC(NC3=CC=C(N4CC[Se]CC4)C=C3)=NC(N[C@@H]5C[Se]CC5)=C1N=CN2
Molecular Formula
C19H23N7Se2
Molecular Weight
507.35
References & Citations
[1]Chang CH, et al. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy. 2019 Mar 1:1-15.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
126627-ML490 100 µL
FARP1 (FERM, RhoGEF and Pleckstrin Domain-containing Protein 1, Chondrocyte-derived Ezrin-like Protein, Pleckstrin Homology Domain-containing Family C Member 2, PH Domain-containing Family C Member 2, CDEP, PLEKHC2) (MaxLight 490)
Sign In for Pricing
View Details 
MBS7174486 Inquire
Rabbit anti-Escherichia coli (strain 55989/EAEC) rpsP Polyclonal Antibody
Sign In for Pricing
View Details MBS3801305-01 48 Well
Human Serine/Threonine Protein Kinase (STK) ELISA Kit
Sign In for Pricing
View Details